Medication & Reduction
How to Taper Benzodiazepines and Z-drugs: Differences in Withdrawal, Rebound, and Tapering Order
When tapering medication, it is essential to protect sleep and daily functioning while reducing the drug's influence. Baekrokdam stabilizes symptoms while continuing existing medication, then selects items with relatively lower dependence and tapering risks, adjusting herbal medicine and acupuncture treatments to manage withdrawal and rebound effects.
BenzodiazepineBoth benzodiazepines and Z-drugs can cause reactions such as insomnia, anxiety, and tremors if stopped abruptly; however, their original purpose, duration of action, period of use, and specific risks during tapering differ. Rather than reducing medication while symptoms are unstable, current discomfort should be treated first before determining the order of tapering.
| Category | Benzodiazepines | Z-drug |
|---|---|---|
| Commonly used situations | Anxiety, panic, insomnia, seizures, etc. | Insomnia characterized by difficulty falling asleep or staying asleep |
| Common issues during dose reduction | Anxiety, insomnia, tremors, sensory hypersensitivity | Rebound insomnia, anxiety, decreased next-day functioning |
| Specific risks to watch for | Severe withdrawal or seizures due to rapid dose reduction | Complex sleep behaviors such as sleepwalking or sleep-driving |
| General principles | Individualized gradual dose reduction | Individualized gradual dose reduction |
Although these two types of medication may seem similar, their original roles are different.
Benzodiazepines are used in various situations such as anxiety, panic, insomnia, and seizures, and their duration of action varies significantly by drug. Z-drugZ-drugs, such as zolpidem, eszopiclone, and zaleplon, are primarily used for insomnia, focusing on the time it takes to fall asleep and maintaining sleep.
Both classes of drugs act on the inhibitory signals of the brain, and the body may adapt to the medication with repeated use. Even with the same dose, the risk associated with tapering varies depending on the duration of use, whether it is taken daily or only as needed, and whether alcohol, painkillers, or other sleep medications are taken concurrently.
For benzodiazepines, both the duration of action and the risk of withdrawal are considered
Medications with a short duration of action may cause prominent anxiety, tremors, or insomnia between doses, while long-acting medications may leave daytime drowsiness and brain fog. The name of the drug alone is not enough. The single dose, daily frequency, and duration of use determine the tapering plan.
Sudden discontinuation or tapering too quickly can cause severe anxiety, insomnia, muscle tremors, and sensory hypersensitivity, and in rare cases, may lead to serious reactions such as seizures and delirium. If you have already taken the medication for a long period, the fact that your body has adapted is not viewed as a failure or a matter of willpower.
Record the medication name, dosage, time of intake, and symptoms following dosage changes in the same record to share with the prescriber.
Z-drugs distinguish between rebound insomnia and complex sleep behaviors
The phenomenon of finding it harder to fall asleep and waking up more frequently for the first few days after reducing Z-drugs may be a 'rebound' effect, where symptoms are temporarily more severe than the original insomnia. If you conclude immediately that the original condition has worsened because of next-day fatigue and anxiety, it becomes difficult to judge the progress of the tapering process.
Complex sleep behaviors, such as walking, driving, cooking, or talking on the phone while not fully awake after taking the medication and not remembering it the next day, are different from general rebound insomnia. If this has occurred, you must consult your prescribing medical staff immediately before the next dose of the medication.
If symptoms are unstable, we build a foundation for recovery while maintaining the medication
If you are barely able to sleep despite taking medication and are experiencing significant throbbing, anxiety, indigestion, or daytime lethargy, it is difficult to begin tapering immediately. First, while continuing the existing medication, we treat the physical discomfort to create a state where sleep and daily life are consistent.
Once resilience improves and the amplitude of symptoms decreases, we select items among various medications that have relatively lower dependency and lower risk when reduced. The selection order is determined by considering the dose, duration, duration of action, current symptoms, and the purpose of the prescription.
When withdrawal or rebound occurs, the speed and focus of treatment are readjusted
Symptoms that were not present before, such as new tremors, sensory hypersensitivity, or nausea appearing after tapering, are viewed first as withdrawal; whereas a temporary increase in original insomnia and anxiety is viewed first as rebound. If previous symptoms return in the same direction over several weeks, Recurrence we also examine the possibilities.
If the reaction is strong, we do not simply endure it or give up on the plan. We pause the tapering stage or adjust it to smaller increments with the prescribing medical staff, and the focus of herbal medicine and acupuncture treatment shifts to the increased sleep, digestion, tension, and body heat issues during that period.
The goal is a day that continues without medication, rather than the date the medication was stopped
Herbal medicine treatment supports recovery during the tapering process by categorizing patients into types: those with shallow sleep, throbbing chest, and rising heat; those with a blocked solar plexus and significant nausea; and those with decreased energy and digestion after long-term use. Acupuncture treatment reduces tension in the neck, chest, and diaphragm and hyperarousallowers it.
The next tapering stage can be reached only when sleep, morning waking, meals, work, and relationships are maintained. The core of Baekrokdam tapering treatment is to increase the resilience of daily life while gradually reducing the influence of the medication.
For benzodiazepines and Z-drugs, sudden discontinuation is avoided. The process follows the order of stabilization, selective tapering considering the risks of each drug, management of withdrawal and rebound, and recovery of daily life. Success in tapering is judged not by the speed of discontinuation, but by whether sleep and life are maintained even as the influence of the medication decreases.
Evidence and Update Information
This content was organized by Korean medicine doctor Choi Yeon-seung based on the materials below and was updated on 2026-08-31.
- NICE NG215: Medicines associated with dependence or withdrawal symptomsGradual reduction of benzodiazepines, Z-drugs, antidepressants, etc., and principles of individual pacing and continuous observation
- ASAM: Joint Clinical Practice Guideline on Benzodiazepine TaperingPrinciples of avoiding abrupt benzodiazepine cessation and individualized tapering under the supervision of a prescriber
- FDA: Benzodiazepine boxed warningSafety warnings regarding the risk of dependence, withdrawal, seizures, and patient-specific tapering plans
- FDA: Boxed warning for prescription insomnia medicinesComplex sleep behaviors and risk of injury associated with certain insomnia medications such as Zolpidem
- NICE NG222: Depression in adultsPrinciples of gradual and proportional reduction when evaluating/treating depression and tapering antidepressants
- Royal College of Psychiatrists: Stopping antidepressantsDistinguishing antidepressant withdrawal symptoms from the recurrence of original symptoms, and reduction plans established with the prescriber
- VA/DoD 2025: Chronic Insomnia Disorder and Obstructive Sleep ApneaAssessment and treatment of chronic insomnia and sleep apnea, and the CBT-I priority principle
- NIMH: DepressionEmotional, cognitive, and physical symptoms of depression and when to seek help